| Citation:Chassid O,Epstein I,Sharabi-Nov A,Pikkel J.Prevalence of glaucoma in the Israeli Arab population.Int J Ophthalmol 2018;11(1):163-165,doi:10.18240/ijo.2018.01.25 |
|
| Prevalence of glaucoma in the Israeli Arab population |
| Received:March 24, 2017 Revised:September 18, 2017 |
| Email this Article Add to Favorites Print |
| DOI：10.18240/ijo.2018.01.25 |
| Key Words:glaucoma Arab trabeculectomy beta-blockers |
| Fund Project: |
| Author | Institution |
| Otzem Chassid |
Department of Ophthalmology, Ziv Medical Center, Safe 13100, Israel |
| Irena Epstein |
Department of Ophthalmology, Ziv Medical Center, Safe 13100, Israel |
| Adi Sharabi-Nov |
Department of Ophthalmology, Ziv Medical Center, Safe 13100, Israel |
| Joseph Pikkel |
Department of Ophthalmology, Ziv Medical Center, Safe 13100, Israel |
|
| Hits: 1102 |
| Download times: 285 |
| Abstract: |
| We describe the prevalence and treatment of glaucoma in a Muslim Arab population in Israel. Based on the medical records of 15 122 persons, the overall prevalence of glaucoma was 3.9%. Prevalence rates of primary open angle glaucoma (POAG) and primary angle-closure glaucoma (PACG) were 3.0% and 0.42%, respectively. Prevalence rates of women were 135% that of men considering all types of glaucoma, 143% for POAG, and 96% for PACG. Prostaglandin analogs and beta blockers, alone or combined with carbonic anhydrase inhibitors, were the preferred medications. Of 68 patients who underwent trabeculectomy, 27 (39.7%) required medications, postoperatively, for treatment of glaucoma; following Ex-Press shunt surgery, 3/11 (27.3%) required medications. During the last three years, 16 (1.3%) individuals with POAG were recorded as legally blind as a result of glaucoma. |
| Supplementary Material |
| PDF Fulltext Download reader View/Add Comment |
|
|
|
|
